• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

外用剂量的接触时间与米诺地尔从局部溶液中的经皮吸收之间的关系。

Relationship between contact time of applied dose and percutaneous absorption of minoxidil from a topical solution.

作者信息

Ferry J J, Shepard J H, Szpunar G J

机构信息

Clinical Pharmacokinetics Unit, Upjohn Company, Kalamazoo, MI 49001.

出版信息

J Pharm Sci. 1990 Jun;79(6):483-6. doi: 10.1002/jps.2600790605.

DOI:10.1002/jps.2600790605
PMID:2395092
Abstract

Twenty-two healthy male volunteers completed a four-way, multiple-dose, randomized crossover study to determine the relationship between contact time of applied drug on the scalp and minoxidil absorption from a 2% topical solution. One milliliter of solution was applied twice daily over 150 cm2 of bald scalp to each subject for 6 days. Unabsorbed drug was washed off the scalp after 1, 2, 4, and 11.5 h of contact time in each of four treatments. Cumulative urinary excretion profiles within steady-state, 12-h dosing intervals were well described by straight lines for all treatments, indicating that systemic minoxidil elimination was rate controlled by constant, zero-order percutaneous drug absorption. The extent of minoxidil absorption, expressed as steady-state urinary excretion of unchanged minoxidil, minoxidil glucuronide, or the sum of these, increased in a disproportionate manner with increase in contact time of drug on the scalp. Relative to the amount absorbed after a contact time of 11.5 h, absorption was approximately 50% complete by 1 h and greater than 75% complete by 4 h. This suggests that minoxidil absorption from the vehicle into skin occurs rapidly relative to diffusion through skin. The rate of minoxidil absorption from vehicle into skin was characterized as nonlinear, whereas minoxidil excretion into urine was rate controlled by diffusion from one or more components of the skin which apparently serve as a reservoir, or depot, for minoxidil.

摘要

22名健康男性志愿者完成了一项四组、多剂量、随机交叉研究,以确定涂抹在头皮上的药物接触时间与2%局部溶液中米诺地尔吸收之间的关系。每天两次将1毫升溶液涂抹在每位受试者150平方厘米的秃头皮上,持续6天。在四种处理中的每一种处理中,分别在接触1、2、4和11.5小时后将未吸收的药物从头皮上冲洗掉。在稳态下,12小时给药间隔内的累积尿排泄曲线在所有处理中均可用直线很好地描述,这表明全身米诺地尔消除受恒定的零级经皮药物吸收速率控制。米诺地尔的吸收程度,以未改变的米诺地尔、米诺地尔葡萄糖醛酸苷或它们的总和的稳态尿排泄量表示,随着药物在头皮上接触时间的增加而成比例增加。相对于接触11.5小时后的吸收量,1小时时吸收约50%完成,4小时时超过75%完成。这表明米诺地尔从载体进入皮肤的吸收相对于通过皮肤的扩散发生得很快。米诺地尔从载体进入皮肤的吸收速率被表征为非线性,而米诺地尔排泄到尿液中的速率受皮肤中一种或多种成分扩散的控制,这些成分显然作为米诺地尔的储存库或 depot。

相似文献

1
Relationship between contact time of applied dose and percutaneous absorption of minoxidil from a topical solution.外用剂量的接触时间与米诺地尔从局部溶液中的经皮吸收之间的关系。
J Pharm Sci. 1990 Jun;79(6):483-6. doi: 10.1002/jps.2600790605.
2
Absorption of minoxidil after topical application: effect of frequency and site of application.局部应用米诺地尔后的吸收:应用频率和部位的影响。
Clin Pharmacol Ther. 1989 Apr;45(4):396-402. doi: 10.1038/clpt.1989.46.
3
Percutaneous absorption of minoxidil in man.米诺地尔在人体中的经皮吸收。
Arch Dermatol. 1985 Feb;121(2):203-6.
4
Influence of tretinoin on the percutaneous absorption of minoxidil from an aqueous topical solution.维甲酸对米诺地尔从水性局部溶液中经皮吸收的影响。
Clin Pharmacol Ther. 1990 Apr;47(4):439-46. doi: 10.1038/clpt.1990.55.
5
Topical minoxidil therapy for hair regrowth.外用米诺地尔治疗促进头发生长。
Clin Pharm. 1987 May;6(5):386-92.
6
Minoxidil: hope for the bald?米诺地尔:脱发者的希望?
Lancet. 1987 May 2;1(8540):1019-22. doi: 10.1016/s0140-6736(87)92281-1.
7
Simultaneous effects of tocopheryl polyethylene glycol succinate (TPGS) on local hair growth promotion and systemic absorption of topically applied minoxidil in a mouse model.生育酚聚乙二醇琥珀酸酯(TPGS)对小鼠模型局部毛发生长促进作用及局部应用米诺地尔全身吸收的同时影响。
Int J Pharm. 2005 Dec 8;306(1-2):91-8. doi: 10.1016/j.ijpharm.2005.09.005. Epub 2005 Oct 25.
8
Drug and vehicle deposition from topical applications: use of in vitro mass balance technique with minoxidil solutions.
J Pharm Sci. 1992 Aug;81(8):736-43. doi: 10.1002/jps.2600810803.
9
The effect of UVB-induced erythema on the percutaneous absorption of minoxidil from an aqueous topical solution.中波紫外线诱导的红斑对米诺地尔水性外用溶液经皮吸收的影响。
Biopharm Drug Dispos. 1990 Oct;11(7):633-7. doi: 10.1002/bdd.2510110708.
10
A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men.一项比较5%外用米诺地尔、2%外用米诺地尔与安慰剂治疗男性雄激素性脱发的随机临床试验。
J Am Acad Dermatol. 2002 Sep;47(3):377-85. doi: 10.1067/mjd.2002.124088.

引用本文的文献

1
Blood pressure changes in patients after Minoxidil microinfusion to treat female pattern alopecia: analysis of a randomized, single blinded, placebo controlled clinical trial.米诺地尔微量输注治疗女性型脱发患者后的血压变化:一项随机、单盲、安慰剂对照临床试验的分析
Arch Dermatol Res. 2025 May 6;317(1):750. doi: 10.1007/s00403-025-04247-2.
2
Combination and Rotational Therapy in Androgenetic Alopecia.雄激素性脱发的联合与轮换疗法
J Cutan Aesthet Surg. 2023 Apr-Jun;16(2):71-80. doi: 10.4103/JCAS.JCAS_212_22.
3
Pharmacological Management of Pattern Hair Loss.
雄激素性脱发的药物治疗
Indian J Plast Surg. 2021 Dec 13;54(4):422-434. doi: 10.1055/s-0041-1739254. eCollection 2021 Oct.
4
Retinal artery occlusion as a probable idiosyncratic reaction to topical minoxidil: a case report.视网膜动脉阻塞可能是局部米诺地尔的特异反应:病例报告。
J Med Case Rep. 2021 Oct 8;15(1):493. doi: 10.1186/s13256-021-03114-8.
5
Minoxidil induced central serous Chorioretinopathy treated with oral Eplerenone - a case report.米诺地尔引起的中心性浆液性脉络膜视网膜病变经口服依普利酮治疗——一例报告。
BMC Ophthalmol. 2020 Jun 5;20(1):219. doi: 10.1186/s12886-020-01499-6.
6
Topical combinations aimed at treating microvascular dysfunction reduce allodynia in rat models of CRPS-I and neuropathic pain.针对治疗微血管功能障碍的局部联合治疗可减少复杂性区域疼痛综合征 I 和神经病理性疼痛大鼠模型中的痛觉过敏。
J Pain. 2013 Jan;14(1):66-78. doi: 10.1016/j.jpain.2012.10.004.
7
Treatments for androgenetic alopecia and alopecia areata: current options and future prospects.雄激素性脱发和斑秃的治疗:当前选择与未来前景
Drugs. 2001;61(1):53-69. doi: 10.2165/00003495-200161010-00006.